The company is a service partner for all aspects of oligonucleotides. It developed and produced the world's first and only translucent orthodontic systems using novel nanotechnology polymer composite products.
A bionanotech designer and maker of nanostructured chips, devices and systems for fast, comprehensive, and low-cost analysis of native state genomic, epigenomic and proteomic information with sensitivity at the single cell / single molecule level.
Bioni's core business is the development, production and marketing of coatings to enhance the walls, facades and roofs of all manner of buildings. Based upon the latest scientific findings in nanotechnology and together with the researchers at the Fraunhofer Institute for Chemical Technology, Bioni has developed an effective nano-filler combination, which when used in both interior and facade paints, permanently prevents the formation of mould, bacteria and algae.
The company's technology is based on the large scale production of nanometric particles known as VLPs (virus like particles). The most advanced application of this technology is the production of viral vector derived vaccines for human and animal health.
The company develops skin care products with its proprietary nanotechnological platform based on the development of Bioactive Complex Modeling (NANO-COMPLEXES™) that has the ability to control nano- and pico- quantities of biologically active substances.
BioPAL provides products and methods to measure in vivo organ function and to track compounds-of-interest in in vivo systems. Products developed for neutron activation technology include nanocolloids for labeling, tracking and quantifying cells in in vivo models.
The company has a polymer micro-system technology platform comprising core intellectual property in the areas of polymer multilevel micro- and nano-replication, plastic micro-fluidic chip fabrication and photonics integration, to provide unique products for point-of-use analytical applications.
BioSolar, Inc. has developed a breakthrough technology to produce bio-based materials from renewable plant sources. Through the advanced manipulation of bio-based polymers, BioSolar intends to produce robust bio-based components that meet the stringent thermal and durability requirements of current solar cell manufacturing processes.
Blend Therapeutics is a biopharmaceutical company discovering new classes of medicines to treat debilitating diseases. The company is pioneering an integrative way to discover molecular entities with new mechanisms of action purposely designed for our proprietary nanoparticles. By synergistically developing both the molecule and the nanoparticle together they can make medicines more targeted, more effective and more tolerable.
Evolved from more than 15 years research at Sydney's Macquarie University, BluGlass has invented a novel process using Remote Plasma Chemical Vapour Deposition (RPCVD) to grow semiconductor materials such as gallium nitride (GaN), crucial to the production of high efficiency devices including next generation lighting technology Light Emitting Diodes (LEDs) at a fraction of the current cost.
BOC Edwards is a leading supplier to the world's most advanced industries including semiconductor, compound semiconductor, chemical, pharmaceutical, metallurgy, scientific instrumentation and research & development.
The company's core competence is the selective modification of glass by generating metal nanoellipsoids inside the glass material.Boraglas develops and commercializes laser-based nanotechnologies especially for glass material which is applied for the manufacturing of nanotechnology products.
BREC Solutions Limited is one of the leading consultancies in nanotechnology innovation. They offer services in research and development, information tracking, technology scouting, standardisation, and regulation briefings. They are part of the increasing number of stakeholder expert groups in nanotechnology where they represent their clients.